Health care stocks were mixed premarket Tuesday, with The Health Care Select Sector SPDR Fund (XLV) marginally higher and the iShares Biotechnology ETF (IBB) down 0.6%.
Illumina (ILMN) is now prohibited from exporting gene sequencers to China as the company was added to the country's "Unreliable Entity List," according to a statement from China's Ministry of Commerce. Illumina shares were down more than 4% pre-bell.
Wave Life Sciences (WVE) stock was nearly 4% higher after the company reported that it swung to Q4 net income as revenue rose during the period.
BeiGene (ONC) shares were up over 2% after the company said the US Food and Drug Administration approved Tevimbra, in combination with platinum-containing chemotherapy, for the first-line treatment of certain adults with unresectable or metastatic esophageal squamous cell carcinoma.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。